TABLE 3.

Spearman correlation between CWD-positive animals and clinical variables^a

Correlation	Obex	RLN	RAMALT		NB RT-QuIC		132MM	132ML	Obex score of:
			IHC analysis	RT-QuIC	KSU	RML			0	1	2	3	4
Positiveb	0.86 (<0.001)c	0.95 (<0.001)	0.83 (<0.001)	0.83 (<0.001)	0.50 (<0.001)	0.48 (<0.001)	0.26 (0.19)	−0.26 (0.19)	−0.86 (<0.001)	0.24 (0.25)	0.17 (1.00)	0.40 (<0.001)	0.59 (<0.001)
RAMALT IHC analysis	0.92 (<0.001)	0.87 (<0.001)	1.0 (<0.001)	0.96 (<0.001)	0.60 (<0.001)	0.58 (<0.001)	0.30 (0.04)	−0.30 (0.04)	−0.92 (<0.001)	−0.01 (1.0)	0.21 (0.69)	0.48 (<0.001)	0.71 (<0.001)
132MM	0.32 (<0.001)	0.23 (0.01)	0.30 (<0.001)	0.30 (<0.001)	0.21 (0.02)	0.20 (0.03)	1.0 (<0.001)	−1.0 (<0.001)	−0.32 (0.02)	−0.01 (1.0)	0.07 (1.0)	0.17 (1.0)	0.25 (0.24)
132ML	−0.32 (<0.001)	−0.23 (0.01)	−0.30 (<0.001)	−0.30 (<0.001)	−0.21 (0.02)	−0.20 (0.03)	−1.0 (<0.001)	1.0 (<0.001)	0.32 (0.02)	0.01 (1.0)	−0.07 (1.0)	−0.17 (1.0)	−0.25 (0.24)

^aIncluding postmortem IHC results, antemortem IHC and RT-QuIC analyses of RAMALT and nasal brushings (NB), the PRNP 132 genotype, and the stage of clinical disease as assessed by obex score.

^bCorrelation applies to tissue correlated with either an obex or an RLN sample that was positive for CWD by IHC analysis.

^cShown are correlations (P values).